Chicago Marriott at Medical District/UIC
625 S Ashland Ave
Chicago, IL 60607
The Midwest CEPAC deliberated and voted on ICER's report on treatments for hereditary transthyretin-related (hATTR) amyloidosis, a rare genetic condition characterized by nerve, heart, and eye damage that is currently treated through supportive measures alone. The Council also reviewd a report on therapies for prostate cancer during this meeting.
Open to public comment until April 2, 2018. Click here for more information on submitting a public comment, please visit our stakeholder engagement page.
Open to public comment until August 17, 2018 at 5pm ET. Click here for more information.